This review will discuss the current literature regarding CVD risk and postmenopausal women’s osteoporosis prevention and treatment options, such as bisphosphonates, estrogen modulators, parathyroid hormone (PTH) analogs, and antiresorptive calcitonin analogs as an alternative therapy [8]. This evidence concerns the gene PTH and osteoporosis.